BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26264164)

  • 1. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
    Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
    Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
    Qian T; Zhang B; Qian C; He Y; Li Y
    Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
    Zhou CX; Zhao JH
    Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
    Mo J; Luo M; Cui J; Zhou S
    Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.
    Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX
    Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between ERCC1 C8092A and ERCC2 K751Q polymorphisms and risk of adult glioma: a meta-analysis.
    Xu Z; Ma W; Gao L; Xing B
    Tumour Biol; 2014 Apr; 35(4):3211-21. PubMed ID: 24254311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
    Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
    Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERCC1 and ERCC2 haplotype modulates induced BPDE-DNA adducts in primary cultured lymphocytes.
    Lu X; Liu Y; Yu T; Xiao S; Bao X; Pan L; Zhu G; Cai Y; Liu Q; Jin C; Yang J; Wu S; An L; van der Straaten T
    PLoS One; 2013; 8(4):e60006. PubMed ID: 23593158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
    Zhao F; Shang Y; Zeng C; Gao D; Li K
    Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
    Chen XJ; Tong ZC; Kang X; Wang ZC; Huang GL; Yang TM; Dong L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6658-6666. PubMed ID: 30402838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.
    Zhou J; Liu ZY; Li CB; Gao S; Ding LH; Wu XL; Wang ZY
    Tumour Biol; 2015 Apr; 36(4):3017-23. PubMed ID: 25542228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer.
    He MG; Zheng K; Tan D; Wang ZX
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of ERCC1 and ERCC2 Gene Polymorphisms with Pancreatic Cancer Risk: A Meta-Analysis.
    Xie F; Sun Q; Zhang E; Mu Y
    Crit Rev Eukaryot Gene Expr; 2020; 30(3):231-237. PubMed ID: 32749109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer.
    Yu WH; Wang YX; Guo JQ; Wang YL; Zheng JS; Zhu KX
    Genet Mol Res; 2015 Dec; 14(4):17529-35. PubMed ID: 26782397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population.
    Ying MF; Zhao R
    Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of ERCC gene polymorphism with osteosarcoma risk.
    Wang G; Li J; Xu X; Gupta RK; Gao X
    Afr Health Sci; 2020 Dec; 20(4):1840-1848. PubMed ID: 34394247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer.
    Joo J; Yoon KA; Hayashi T; Kong SY; Shin HJ; Park B; Kim YM; Hwang SH; Kim J; Shin A; Kim JY
    Cancer Res Treat; 2016 Apr; 48(2):708-14. PubMed ID: 26130668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
    Xin Y; Hao S; Lu J; Wang Q; Zhang L
    PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
    Li Y; Liu Z; Liu H; Wang LE; Tan D; Ajani JA; Wei QY
    PLoS One; 2013; 8(9):e71994. PubMed ID: 24023723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
    Zhang H; Ge J; Hong H; Bi L; Sun Z
    World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.